Choi et al. demonstrated that CXCR4, but not CXCR7, is essential for CXCL12-mediated metastasis, supporting CXCR4 inhibition as a strategy to prevent NSCLC progression (Choi et al., 2014). This evidence concerns the gene CXCL12 and non-small cell lung carcinoma.